Category:ABA Keywords

From My wiki

(Redirected from ABA Key Words)
Jump to: navigation, search

Below are the key words and phrases from the 2008 through 2012 ABA inservice training (ITE) exams, followed by the percent of residents in their final year of training who answered the question pertaining to the key word correctly. Some (and soon, hopefully all) of these key words and phrases are discussed in detail on this site - click on the links to read more:

(note: please see our policy on Policy on Evidence Based Medicine and help us make these answers more robust by adding appropriate citations)

Studying for exams? Answer the Review Question of the Day, many of which are based upon ABA Keywords.

Contents

Anatomy

Atlantoaxial instability: Causes (98% in 2012)
Cardiac anatomy: TEE (5% in 2013)
Cardiac surface anatomy (34% in 2008)
Caudal anesthesia: Anatomy (73% in 2012)
Cervical fracture, Intubation techniques (75% in 2010)
Coronary Artery: anatomy (81% in 2009, 81% in 2012)
Dural sac: Anatomy (46% in 2013)
Epidural anatomy (83% in 2012)
Ilioinguinal anatomy (63% in 2013)
Nerve block landmarks (48% in 2009, 49% in 2012)
Peripheral nerves: Sensory vs motor (82% in 2009, 84% in 2012)
Pharyngeal reflex: Innervation (94% in 2013)
R vs L IJ cath complications (96% in 2012)
Recurrent laryngeal nerve injury (91% in 2012)
Sciatic nerve block: Anatomy (56% in 2013)
Spinal anes anatomy: Paramedian (68% in 2011)
Spinal cord anatomy (52% in 2008)
Spinal cord: blood flow (32% in 2008)
Superior laryngeal nerve anatomy (80% in 2010)

Organ Based Clinical

Neurologic

Autonomic dysreflexia symptoms (87% in 2013)
Autonomic hyperreflexia risk factors (89% in 2011)
Autonomic hyperreflexia: Signs (74% in 2012)
Becker's muscular dystrophy: Rhabdomy (93% in 2013)
Blood brain barrier: Fluid transfer (78% in 2010)
Brain stem surg manip: Hypertension (82% in 2011)
Carbon monoxide poisoning: Dx (71% in 2012)
Carotid Endarterectomy: CNS monitoring (63% in 2009, 70% in 2012)
Cerebral Aneurysm clipping: anes management (58% in 2009)
Cerebral aneurysm: Transmural pressure (21% in 2013)
Cerebral blood flow: Temperature effect (75% in 2010)
Cerebral ischemia: deep hypothermia (63% in 2009)
Cerebral vasospasm: treatment (82% in 2008, 70% in 2010, 87% in 2011, 89% in 2012)
Craniotomy: positioning injury (73% in 2008)
Definition: Coma vs vegetative state (79% in 2013)
Diabetes insipidus intracranial surg (93% in 2009)
Duchenne’s: Cardiac implications (48% in 2012)
Duchenne’s: PFTs (86% in 2013)
Eaton-Lambert: Mechanism (75% in 2012)
ECT: anesthetic agents and seizure duration (59% in 2008)
ECT: seizure duration (46% in 2008)
ECT: side effects (95% in 2009)
Elevated ICP: Hyperventilation (80% in 2012)
Evoked potentials: anesthetic effects (55% in 2008, 83% in 2010)
Fluids: traumatic brain injury (84% in 2008)
Glasgow coma scale: definition (90% in 2009, 94% in 2010, 99% in 2012)
Hypertension: brainstem surgery (73% in 2008)
ICP: tumor: corrected mechanism (57% in 2008)
Increased ICP: Acute treatment (38% in 2010)
Increased ICP: induction agents (97% in 2011)
Multiple sclerosis: Periop mgmt (65% in 2012)
Multiple sclerosis: Risk of pulm comp (8% in 2013)
Myasthenia gravis: postop management (27% in 2009, 68% in 2009)
Oculocardiac reflex: afferent path (52% in 2008, 99% in 2009, 70% in 2011)
Periodic paralyses: Hyperglycemia (61% in 2013)
Periph compartment syndrome Dx (52% in 2011)
Phenytoin: Neuromusc block effect (66% in 2012)
Post-dural puncture headache: risk factors (91% in 2010)
Postherpetic neuralgia Rx (80% in 2011)
Postop diabetes insipidus: Rx (97% in 2012)
Pseudotumor cerebri: LP effect (52% in 2011)
Rx of intracranial hypertension in CHF (65% in 2012)
Saphenous nerve damage: signs (82% in 2011)
Subarachnoid hemorrhage complication (82% in 2013)
Subarachnoid hemorrage: nimodipine (87% in 2009)
Sux in neuromuscular disease (88% in 2012)
Sux side effects (98% in 2013)
Sweat glands: Innervation (30% in 2012)
Thiopental therapeutic coma (79% in 2008, 73% in 2012)
Thiopental: CMRO2/CBF relationship (86% in 2010)
Traumatic Brain Injury: CPP (33% in 2010)
Treatment of increased ICP (98% in 2008)

Cardiovascular

AICD malfxn: Causes (49% in 2012)
Air embolism: Dx (79% in 2012)
Aortic clamping: ischemia mechanism (88% in 2008)
Aortic crossclamp: CV complications (65% in 2010)
Aortic insufficiency: Hemodynamic treatment (88% in 2010)
Aortic insufficiency: medical management (87% in 2008, 81% in 2011)
Aortic stenosis: A fib Rx (65% in 2011)
Aortic stenosis: Hypotension Rx (81% in 2012)
AS and arrhythmias (91% in 2013)
Atrial flutter: Pharmacologic treatment (37% in 2010)
Barb coma: EEG endpoint (62% in 2011)
Bradycardia and heart transplant (67% in 2013)
Calculation pulmonary vs systemic vascular resistance (84% in 2009)
Cardiac arrest: Induced hypothermia (74% in 2010)
Cardiac cycle: ECG (12% in 2010)
Cardiac morbidity: Pre-op factors (34% in 2010)
Cardiopulmonary bypass management (33% in 2009)
Carotid sinus reflex: Rx (98% in 2012)
Carotid sinus stim: post-heart transplant (76% in 2009)
Cardiac tamponade: Dx (88% in 2013)
CHF Frank Starl curve: Milrinone eff (57% in 2011)
CHF Frank Starl curve: Phenylephrine (35% in 2011)
CHF: Frank-Starling curve (71% in 2012)
Complete heart block: Rx (54% in 2012)
Congenital Long QT:management (16% in 2009)
Coronary perfusion pressure (95% in 2010)
DDD pacemaker periop mgmt (71% in 2011)
Doxorubicin: Adverse effects (92% in 2012)
ECT & heart dis: Anesth consid (87% in 2011)
Factors affecting defibrillation (45% in 2013)
Factors affecting turbulent flow (71% in 2009)
Fat embolism: Dx (78% in 2009)
Heart transplant: autonomic effect (81% in 2009, 88% in 2012)
Heart transplant: autonomic pharmacology (85% in 2010)
Heparin resistance: Rx (97% in 2012)
HOCM anesthetic mgmt (85% in 2011)
HOCM: hypotension Rx (89% in 2009)
Hypothermia: pH stat management (53% in 2010)
IABP: Contraindications (86% in 2010)
IHSS: Treatment (84% in 2012)
LV failure: Diagnosis and treatment post-CPB (37% in 2010)
Mitral insufficiency: medical management (77% in 2008, 63% in 2011)
Myocard ischemia intraop Dx/Rx (96% in 2011)
Myocardial ischemia: Acute MR (81% in 2010)
Myocardial O2 consumption: determinants (82% in 2009)
Old MI: Preoperative risk assessment (68% in 2010)
Organ donor: bradycardia Rx (51% in 2009)
Pacemaker & electrocautery (76% in 2012)
Pacemaker Designation (59% in 2009)
PDA repair: Recurrent laryng N injury (78% in 2011)
Perioperative risk of MI (47% in 2012)
Polymorphic VT: Rx (56% in 2012)
Post CPB management: SVR (86% in 2013)
Post-cardiac transplant patient (74% in 2008)
Pulmonary embolism: Pathophysiology (95% in 2013)
Pulmonary hypertension: Dx (47% in 2012)
Pulseless Vtach Rx (77% in 2011)
Renal failure: CPB surgery (75% in 2012)
Rx of periop SVT (92% in 2013)
SBE prophylaxis (45% in 2009)
Subarachnoid bleed: ECG effects (62% in 2010)
Synchronized electrical cardioversion (68% in 2009)
Syst vs Diast heart failure: Dx (74% in 2013)
TEF: Assoc anomalies (85% in 2011)
TEF: Other abnormalities (70% in 2010)
Thoracoscopy: Hypoxemia treatment (42% in 2010)
Torsade de Pointes: Treatment (83% in 2013)
Transcutaneous pacing modes (80% in 2011)
Transcutaneous pacing (74% in 2008)
Tx hypertension: Parkinson's (84% in 2013)
Ventricular hypertrophy (72% in 2008)
Ventricular PV loops (76% in 2009)
VF: Epinephrine mechanism (28% in 2010)

Respiratory/Pulmonary

Abd aortic clamp: Myocard isch mech (90% in 2011)
ABG: COPD (78% in 2012)
ABG: Opioid effect (74% in 2009, 75% in 2012)
ABG: Pulm embolism (62% in 2012)
ABG: Salicylate toxicity (93% in 2012)
Air embolism Dx (65% in 2009, 81% in 2009)
Ant mediastinal mass: Anes effects (87% in 2011)
Anesth. mgmt: Asthma (83% in 2012)
ARDS: Optimal tidal volume (83% in 2011)
ARDS: Prone position mech. (55% in 2011)
Ascites: PFT's (51.5% in 2008)
Atelectasis during anesthesia: Etiol (57% in 2012)
Atlantoaxial instability: causes (96% in 2009)
Bronchial blocker: Advantages (74% in 2010)
Bronchodilation: Anes drugs (89% in 2011)
Bronchopleural fistula: Ventilator management (73% in 2010)
Bronchospasm: acute treatment (90% in 2008)
Bronchospasm: mechanical ventilation Dx (88% in 2009, 89% in 2012)
Bronchospasm triggers: ETT (82% in 2010)
Carbon Monoxide

Central sleep apnea vs. OSA (57% in 2012)
CO diffus capacity: Abnormal DDx (88% in 2011)
CO2 response curve (54% in 2011)
Demyelinating diseases: PFTs (88% in 2011)
Diagnosis of croup (99% in 2008)
Elevated FRC DDx (79% in 2011)
FB Aspiration: physical exam (73% in 2009)
FV loop: mediastinal mass (66% in 2008)
Geriatrics: Pulmonary changes (85% in 2011)
Heliox: Airway resistance (90% in 2011)
Hemodynamics of laryngoscopy (59% in 2008)
Interscalene block: Complications (94% in 2012)
Low tidal volume ventilation: Protective effect (87% in 2010)
Lung resection outcome: PFTs (9% in 2009, 84% in 2012)
Metabolic alkalosis: Respiratory compensation (79% in 2010)
Mgmnt of hypoxemia during OLV (78% in 2012)
Obstructive Sleep Apnea: Diagnosis (94% in 2008, 85% in 2009)
One lung vent: O2 desat Rx (72% in 2011)
Oxygenation during one-lung ventilation (63% in 2008)
PFTs: DLCO (82% in 2012)
Postobstructive pulmonary edema (80% in 2011)
Post-op hypotension: Pulm emb (80% in 2011)
Pressure vs. volume ventilation: ICU (94% in 2010)
Pulmonary aspiration treatment (73% in 2011)
Pulmonary Embolism

Respiratory distress syndrome: effects (peds) (68% in 2008)
Restrictive lung disease: diagnosis (96% in 2008, 94% in 2012)
Rheumatoid arthr complications (59% in 2012)
Shunt: effect of increased FiO2 (48% in 2009)
Smoking cessation: acute physiology (63% in 2009, 90% in 2010)
Smoking cessation: P50 effect (63% in 2011)
Tension pneumothorax: Dx and Rx (95% in 2009, 77% in 2010)
TRALI: Treatment (48% in 2010)
Ventilation modes: Pressure waveform (74% in 2010)
Ventilator disconnect: Detection (72% in 2010)
Ventilator settings: atelectasis (74% in 2008)
Ventilator: low tidal volume (87% in 2009)
Wall oxygen failure: Signs (53% in 2010)

Renal/Urine/Electrolytes

Acidosis: Nonanion gap DDx (93% in 2011)
Anticholinesterases in CRF (61% in 2012)
Causes of atrial fibrillation (84% in 2013)
Contrast CT: Renal fxn preservation (68% in 2011)
ETOHism: Electrolyte abnormalities (63% in 2011)
FENa in hypovolemia (51% in 2012)
Hemodialysis effects (72% in 2008)
Hyperkalemia treatment (73% in 2010)
Hypermagnesemia treatment (67% in 2010)
Intraoperative oliguria: hyperventilation (38% in 2008)
Perioperative renal failure: Predictor (6% in 2013)
Post-CPB creatinine increase: Differential diagnosis (85% in 2010)
Prerenal oliguria Dx/Rx (71% in 2011)
Renal Failure/Insufficiency (also see section on Renal Disease (Anesthesia Text))

Renal transplant: mannitol (54% in 2008, 54% in 2011)
Renin-angiotensin CV physiology (77% in 2010)
Robotic prostatectomy: contraindications (66% in 2009)
Saline: hyperchloremic acidosis (97% in 2010)
SIADH: lab findings (49% in 2008, 84% in 2010, 64% in 2011)
TURP: Irrigating fluid complications (51% in 2013)
TURP syndrome: Treatment (54% in 2010, 90% in 2012)
Vasopressin Rx diabetes insipidus (55% in 2009)

Hepatic

Hepatic dysfunction: Dx (67% in 2009)
Hepatic synthesis impairment: Diagnosis (71% in 2009, 45% in 2010)
Hepatic synthetic function: Labs (82% in 2011)
Hepatic synthetic function: PT (82% in 2008)
Hepatitis B: Needle stick diagnosis (88% in 2010)
Liver transplantation: Electrolyte disturbances (86% in 2011)
Postop hepatic dysfunct: Risk factors (45% in 2011)
Postoperative jaundice: Differential diagnosis (58% in 2010)

Endocrine/Metabolic

Addison's Disease

Carcinoid syndrome (69% in 2008, 58% in 2012)
Carcinoid crisis: treatment (67% in 2010)
Corticosteroid defic in ICU (92% in 2011)
Diabetes: Autonomic neurop signs (79% in 2011)
Diabetes insipidus: Rx (63% in 2012)
DKA treatment (93% in 2012)
Dx: Myxedema coma (62% in 2013)
Electrolyte Homeostasis: hormones (35% in 2009)
Hormonal stress response (51% in 2009)
Hyperaldosteronism: Drug treatment (93% in 2008)
Hypercalcemia: Acute treatment (67% in 2010)
Hyperglycemia: complications (81% in 2009)
Hyperglycemia: Preoperative treatment (88% in 2010)
Hypoparathyroidism: Rx (95% in 2012)
Hyperparathyroidism: signs (31% in 2009, 33% in 2010, 54% in 2012)
Hyperthyroidism: signs (37% in 2009)
Hypocalcemia: ECG effects (75% in 2010)
Hypoglycemia: glucagon (76% in 2008)
Latex allergy: Foods (50% in 2010)
Latex allergy treatment (99% in 2011)
Metformin: Complications (97% in 2013)
MH vs. thyroid storm (91% in 2008, 91% in 2011)
Organ donor: treatment of DI (89% in 2008)
Parathyroidectomy: Cx (31% in 2013)
Pheochromocytoma

Postop oliguria: Endocrine causes (89% in 2011)
SIADH: Electrolytes (96% in 2012)
Steroid prophylaxis indications (63% in 2009, 69% in 2012)
Thyroidectomy: complications (47% in 2008)
Thyroidectomy: hypocalcemia (77% in 2009, 67% in 2010)
Thyrotoxicosis: Rx (24% in 2013)
Transphenoidal surgery: DI Rx (88% in 2013)

Hematologic

ABG: Hypovent in PACU (52% in 2011)
Acetylcholine release: Physiology (88% in 2013)
Awake acute blood loss acid-base (63% in 2011)
Benzocaine & methemoglobinemia (98% in 2013)
Blood transfusion refusal (60% in 2011)
Cryoprecipitate: fibrinogen content (86% in 2009, 81% in 2012)
Crystalloid resusc: Coagulopathy (73% in 2011)
Crystalloid resuscitation: coagulopathy (84% in 2008)
Desmopressin for von Willebrand (74% in 2009)
DM control: Glycosylated Hgb (98% in 2011)
Elevated INR: Factor treatment (76% in 2010)
Enoxaparin: assessment of effect (83% in 2008)
Factor V Leiden: Treatment (90% in 2012)
Factor VIII antibodies: Rx (92% in 2012)
Factor VIII Concentrate: indications (93% in 2009)
Febrile transfusion reaction (40% in 2008)
FFP: Contraindications (67% in 2013)
FFP: Citrate toxicity Dx/Rx (60% in 2011)
FFP: indications (26% in 2008, 60% in 2010)
FFP: warfarin reversal (94% in 2009)
Hemodialysis: Lab effects (68% in 2011)
Hemolysis: bilirubin levels (65% in 2009)
Hetastarch: platelet function (82% in 2009)
IgA deficiency and transfusion (76% in 2012)
Leukoreduction: Viral transmission (31% in 2010)
Maximum ABL calculation (62% in 2010)
Metformin: Contrast dye (88% in 2012)
Methemoglobinemia: diagnosis (78% in 2008, 95% in 2011)
Methemoglobinemia: Treatment (79% in 2010)
Morbid obesity: DVT (90% in 2008)
Multiple myeloma: Symptoms (93% in 2011)
Oxygen delivery: Factors impacting (62% in 2013)
PaO2: temperature correction (51% in 2008)
Peripheral oxygen delivery (30% in 2008)
Positive type and screen Rx (85% in 2011)
Refusal of blood transfusion (65% in 2008)
Rx: Antithrombin 3 deficiency (82% in 2009, 87% in 2012)
SpO2 effect of methemoglobin (88% in 2009)
TRALI: Findings on CXR (74% in 2012)
TRALI: Leukopenia (37% in 2013)
Transfusion mortality: Causes (47% in 2010)
Transfusion: Bacterial sepsis (84% in 2008, 89% in 2011)
Transfusion rxn: Lab findings (36% in 2013)
Transfusion rxn: Mgmnt (96% in 2013)
Type and Screen (unknown)
von Willebrand disease: Rx (65% in 2012)

Neuromuscular Diseases and Disorders

Advanced multiple sclerosis: anesthetic drugs (69% in 2009, 80% in 2012)
Anticholinesterase poisoning: Rx (71% in 2011)
Hyperkal periodic paralysis triggers (63% in 2011)
Multiple sclerosis: exacerbation (49% in 2009, 60% in 2010)
Myasthenia gravis preop risk eval (54% in 2011)
Myasthenic Synd vs Myas Gravis: Sx (64% in 2011)
Myotonic dystrophy: Aspiration risk (76% in 2010)
NM transmission: Ions (73% in 2011)
NMBs in CRF (99% in 2011)
NMBs: ED95 definition (23% in 2011)
NMJ AChR upregulation causes (67% in 2011)
Organophosphate poisoning: diagnosis and treatment (37% in 2008, 69% in 2010)
Rheumatoid arthritis complications (52% in 2009)

Pharmacology

2-Chloroprocaine onset (45% in 2010)
ACE-I: Contraindication (91% in 2012)
ACE Inhibitors: MI survival (76% in 2011)
Acetaminophen toxicity (84% in 2010)
Acetazolamide: mechanism of action (65% in 2008, 79% in 2011)
Albuterol vs ipratropium pharm (89% in 2011)
Alveolar gas exchange (85% in 2013)
Amiloride: Electrolyte effects (64% in 2011)
Amiodarone side effects (65% in 2011)
Amiodarone: hemodynamic effect (49% in 2010)
Amiloride: physiologic effects (77% in 2008)
Anaphylaxis: Epinephrine treatment (90% in 2010)
Antiplatelet drugs: Comparison (71% in 2012)
Antithrombotic drugs: duration (87% in 2008)
Antithrombotic drugs: Preop mgmt (86% in 2011)
Aspirin toxicity: treatment (79% in 2008)
Aspirin: platelet effect (96% in 2008)
Anesthetic Uptake and Distribution (also see section on Inhaled Anesthetics)

Barbiturate enzyme induction (48% in 2013)
Benzodiazepines: respiratory effects (96% in 2008)
B-blockers: Properties (8% in 2013)
Bicarb admin: CO2 effect (87% in 2009, 88% in 2012)
Bupivacaine toxicity Rx (65% in 2009)
Butyrylcholinesterase deficiency (72% in 2008)
Calcium channel blocker: NM blockade (80% in 2012)
Calcium: ECG changes (7% in 2013)
Carbamazepine toxicity (74% in 2010)
Cbf/CMRO2 drug effects (83% in 2011)
Chloroprocaine metabolism (90% in 2009)
Chloroprocaine placental transfer (75% in 2009, 81% in 2012)
Chronic opioids: side effects (91% in 2009)
Cirrhosis: NMB kinetics (97% in 2009, 92% in 2010)
Concentration effect (71% in 2013)
Context-sensitive half time (82% in 2011)
CPB antifibrinolytics (73% in 2008)
CV pharmacology: catecholamines (84% in 2008)
Desflurane vaporization physics (96% in 2011)
Dexmedetomidine: Hemodynamic effects (90% in 2012)
Doxorubicin: Complications (87% in 2010)
Effects of flumazenil (76% in 2013)
Effects of vasopressin vs epi (62% in 2011)
EEG: high dose opiates (34% in 2008)
EMLA contraindications (47% in 2008)
Enoxaparin: Assessment of effect (82% in 2011)
Epidural clonidine: mechanism of action (61% in 2008)
Epidural: Clonidine vs morphine (97% in 2011)
Epidural local anes: GI effect (53% in 2011)
Epidural local anesthetic: peristalsis effect (63% in 2008)
Epidural test dose: Sx (88% in 2009)
Etomidate: Adrenal suppression (93% in 2011)
FA/FI volitile anesthetics (91% in 2013)
Factors affect anes depth (74% in 2013)
Fenoldopam: Renal effects (55% in 2010)
H2-blockers: Onset time (70% in 2010, 74% in 2013)
HCTZ: mechanism of action (52% in 2008)
Herbal medicines: anticoagulation effects (64% in 2008)
Herbal meds: Anticoag effects (69% in 2011)
Herbals: garlic (95% in 2009)
Herbal supplements (98% in 2013)
Hydrochlorothiazide: Blood chemistry effects (24% in 2010)
Hyperbaric N2O (77% in 2013)
Hyperkalemia: drugs causing (48% in 2009)
Identification epileptic foci: Drugs (91% in 2012)
Inotropes: Alpha-1 activity (92% in 2012)
Isoflurane: CMRO2 effect (88% in 2009)
Intestinal obstruction: N2O (53% in 2008)
IV anesthetics: Pain on injection (4% in 2013)
Ketamine analgesic mechanism (95% in 2010)
Ketamine: Pheochromocytoma (94% in 2010)
Ketamine receptor effects (82% in 2009)
Ketamine side effects (92% in 2012)
Lithium and muscle relaxants (47% in 2013)
LMWH: Mechanism of action (67% in 2012)
Local anesthetic: Methemoglobinemia (94% in 2010)
Local anes onset: Factors influencing (76% in 2013)
Local anesthetics: systemic toxicity (76% in 2008)
Local anesthetic: Transient neurologic symptoms (69% in 2010)
Long QT syndrome: Medications (9% in 2013)
MAC: factors affecting (93% in 2011)
Magnesium complications (76% in 2009)
Magnesium: side effects
Malignant hyperthermia: Periop mgmt (9% in 2013)
Mannitol osmolarity effects (41% in 2009)
MAO inhibitor: meperidine toxicity (91% in 2009)
Meperidine: Renal Failure (98% in 2013)
Metformin/Contrast dye interaction (83% in 2009)
Methadone: QT interval (52% in 2011)
Methadone treatment management (98% in 2009)
Metoclopramide: esophageal sphincter tone (79% in 2009, 80% in 2012)
Metoclopramide: gastric effects (95% in 2009)
MgSO4: Cardiac effects (91% in 2012)
Midazolam: Bioavailability versus Route (2010)
Midazolam: Peds oral dosage (86% in 2011)
Milrinone: CV effects (89% in 2010, 92% in 2011)
Milrinone: pharmacology (78% in 2009, 78% in 2012)
Muscle relaxation: Anes agents (86% in 2011)
Muscle relaxation: Mechanism (59% in 2008)
Nalbuphine: Plateau effect mechanisms (73% in 2010)
Neostigmine: Max dose rationale (51% in 2011)
Neostigmine: muscarinic effect (77% in 2008)
Neostigmine: Muscarinic effects (87% in 2011)
Neuraxial opioid action site (62% in 2010)
Neuraxial opioids: tolerance (86% in 2008)
Neuromuscular blocking agents (also see section on Neuromuscular Blockade)

Nitroprusside toxicity: blood chemistry (35% in 2008)
Nitroprusside toxicity Treatment (25% in 2010)
Nitrous oxide: bowel distention (74% in 2008, 77% in 2012)
Nitrous Oxide: CBF and CMRO2 (35% in 2010)
NMB: Rhabdomyolysis (75% in 2013)
NO hemodynamic effect (79% in 2010)
Norepinephrine: CV effects (59% in 2012)
Opioid neurotoxicity: treatment (47% in 2010)
Opioid Reversal (26% in 2009)
Oral Clonidine (84% in 2010)
Organophosphate poisoning: Rx (65% in 2012)
Oxytocin: Electrolyte effects (39% in 2010)
Periop anaphylaxis etiology (71% in 2012)
Periop antihypertensive drug mgmt (88% in 2011)
Phase II depolarizing blockade (6% in 2013)
Phenytoin: Ion channels (68% in 2012)
Plt inhibitor drugs: Tirofiban mech (31% in 2011)
Prolonged NMB risk factors (86% in 2011)
Propofol Infusion syndrome: Dx (27% in 2009)
Propofol mechanism of action (97% in 2011)
QT prolongation with antiemetics
Ritodrine: effects (28% in 2008)
SBE prophylaxis indications (82% in 2011)
Second gas effect (95% in 2013)
Sepsis: Vasopressin (69% in 2012)
Side effects of etomidate (88% in 2013)
Side effects of tocolytics (47% in 2009, 51% in 2012)
Sites of NO production (97% in 2012)
Succinylcholine (also see section on Succinylcholine)

Surgical stimulation: Effect on MAC (69% in 2010)
Systemic Effects of Ketamine (unknown)
Thiopental: CMRO2/CBF relationship (86% in 2010)
Thiopental therapeutic coma (79% in 2008, 73% in 2012)
Thiopental termination of action (95% in 2011)
TNS: Lidocaine (90% in 2011)
Uptake and dist: Infant vs. adult (58% in 2011)
Vasodilator pharmacokinetics (46% in 2009)
Vasopressin Rx diabetes insipidus (55% in 2009)
Vasopressin: pharmacology
Vasopressors: risk of myocardial ischemia (90% in 2009)
Verapamil dantrolene interaction (56% in 2008)
VF: Epinephrine mechanism (28% in 2010)

Physics, Monitoring, and Anesthesia Delivery Devices

Arterial waveform: Peripheral vs. Central (65% in 2010)
Ascending vent bellows advantages (85% in 2011)
Brachial artery catheter: Cx (78% in 2009)
Capnogram waveform: obstruction (61% in 2008)
Cardiac pacemaker indications (61% in 2010)
Clark electrode (61% in 2013)
CO2 absorbers: volatile anes toxicity (83% in 2009, 87% in 2012)
Cylinder content: weight vs. pressure (86% in 2008, 93% in 2011)
Doppler shift & angle of incidence (33% in 2012)
E cylinder: N2O content (84% in 2013)
E-cylindr PSI/vol relationship (89% in 2011)
ECG leads: P-wave detection (83% in 2010)
ECG loose lead effect (29% in 2009)
Factors affecting vaporizer output (60% in 2012)
Flowmeter: Gas properties (56% in 2010)
Gas laws: temp/pressure changes (23% in 2009)
Incompetent expiratory valve: Signs (80% in 2010)
Inhaled anesthetic: Uptake (88% in 2012)
Inhaled anesthetics: vapor pressure (39% in 2008)
Isoflurane: CMRO2 effect (90% in 2012)
Line isolation monitor (25% in 2008)
Mapleson D: Rebreathing (98% in 2010)
Mask CPAP: Physiologic effects (87% in 2010)
MRI: monitoring hazards (80% in 2009)
O2 E cylinder (56% in 2008)
Oxygen regulator: Characteristics (91% in 2012)
Pacer lead placement: ECG morphology (76% in 2010)
Phrenic N stim: Side effects (24% in 2011)
Poiseuille's law: IV fluids (45% in 2012)
SSEP latency: anesthetic drugs (68% in 2009)
SSEP monitoring: Anes effects (98% in 2013)
SSEP: physiological effects (59% in 2008)
Sub-ambient pressure alarm (49% in 2012)
TCD: Utility in CEA (37% in 2011)
TEE views: perfusion distribution (22% in 2008)
TEE: diagnosis: hypotension
TEE: Tamponade vs hypovolemia (69% in 2012)
TEG: Decreased MA Dx/Rx (64% in 2011)
Ultrasonography: internal jugular (93% in 2008, 93% in 2010)
Ultrasound structures: echogenicity (70% in 2009)
Ultrasound: Acoustic impedance (82% in 2011)
Uncuffed ETT: Max leak pressure (81% in 2010)
Vaporizer output at altitude (75% in 2008)
Vaporizer output calculation (25% in 2010)

Physiology

Neurologic

Ant cerebral art stroke effects (25% in 2011)
Autonomic Hyperreflexia (63% in 2009, 82% in 2009)
Autonomic Innervation: upper extremity (87% in 2009)
Autonomic neurotransmitters (50% in 2009, 57% in 2012)
Brain death pathophysiology (82% in 2009)
Brain: ketone metabolism (60% in 2008)
Causes of Upregulations of NAChR (56% in 2008)
Cerebral autoregulation (42% in 2012)
Dural sac: Caudal extent (33% in 2010)
Intracranial aneurysm: IV fluids (80% in 2011)
Lambert-Eaton Syndrome: Physiology (73% in 2010)
Laryngeal innervation (64% in 2011)
Myasthenia: physiology (91% in 2008)
Nerve action potential termination mechanism (70% in 2010)
Paraplegia: Autonomic hyperreflexia (66% in 2010)
Pituitary adenoma: deficiencies (89% in 2008, 94% in 2011)
Preoptic anterior hypothalamus: diagnosis (94% in 2008)
Recurrent laryngeal nerve injury (85% in 2008)
Unilateral blindness: etiology (95% in 2009)

Cardiovascular

Air embolism Dx (65% in 2009, 81% in 2009)
Air embolism: treatment (98% in 2008, 99% in 2011)
Air trapping: Ventilator management (90% in 2010)
Amiloride: physiologic effects (77% in 2008)
AV pacing: Hemodynamic effect (51% in 2010)
Bilateral carotid endarterectomy: Physiology (69% in 2010)
Bradycardia during carotid surgery (82% in 2009)
Cardiac PV loops (84% in 2013)
Cardiac tamponade: Pulsus paradoxus (94% in 2010)
Carotid stent: Bradycardia cause (97% in 2010)
Carotid stent: Bradycardia prevention (97% in 2010)
Circulator arrest: pH-stat implications (12% in 2010)
Constrictive Pericarditis: Venous waveform (50% in 2009, 51% in 2012)
Coronary perfusion pressure: L vs. R (27% in 2009)
CV physiology: LV (52% in 2008)
CV physiology: mixed venous oxygen (52% in 2008)
Denervated heart: exercise physiology (77% in 2009)
Heart block: Coronary occlusion (67% in 2010)
Hemodynamic effects of alpha blockers (84% in 2008)
Hypoplastic left heart physiol (89% in 2011)
Intra-art SBP amplification mech (17% in 2011)
Lusitropy: PV loop (83% in 2011)
LV filling physiology (35% in 2011)
LV pressure-volume relations: Impact of preload (71% in 2012)
Post-cardiac transplant physiol (87% in 2011)
Pulmonary vs SVR: Calculation (92% in 2012)
Spinal hypotension: treatment (97% in 2010)
Stroke volume: Atrial fibrillation effects (72% in 2010)
SvO2 physiology (80% in 2009, 85% in 2012)
Uterine blood flow determinants (83% in 2012)
Vasodilator pharmacodynamics (86% in 2012)
Venous air embolism (45% in 2009, 87% in 2010)

Respiratory

Anterior mediastinal mass: effects (87% in 2008)
Ascites: PFT's (52% in 2011)
Bicarb admin: CO2 effect (87% in 2009)
Bronchomotor tone: Catecholamines (83% in 2011)
Carotid body: Hypoxic drive (49% in 2009, 45% in 2012)
Chest wall compliance: Calculation (11% in 2012)
CO2 response curve (62% in 2008)
CO2 transport: bicarbonate (56% in 2009)
FRC: definition (70% in 2010)
FRC: diseases affecting (89% in 2008)
CO2 dissociation curve (51% in 2013)
FRC: Ventilatory setting effects (91% in 2010)
Haldane effect (47% in 2012)
High A-a gradient: Causes (84% in 2012)
Hypercarbia: alveolar gas equation
Hypercarbia: O2 release to tissues (78% in 2009, 84% in 2012)
Hypoxic pulmonary vasoconstriction (86% in 2013)
Hypoxic pulmonary vasodilation (27% in 2008)
Impact of pH on O2 delivery to tissue (9% in 2013)
Intrapulmonary shunt and O2 Tx (63% in 2013)
Level of hypoxemia: Factors impacting (97% in 2013)
Lungs: Metabolic function (14% in 2013)
Morbid obesity: Hypoxemia physiology (43% in 2010)
Morbid obesity: PFTs (65% in 2008, 82% in 2011)
Morbid obesity: rapid desaturation (51% in 2009, 55% in 2012)
Negative pressure pulmonary edema: Physiology (69% in 2010)
O2 delivery vs. PaO2 (21% in 2008, 44% in 2012)
O2 release (87% in 2010)
Peak vs. plateau airway pressure (76% in 2009)
PEEP to treat hypoxia (86% in 2009)
PEEP: Effect on PAOP (58% in 2010)
PEEP: Lung volume effect (30% in 2010)
PEEP: LV effects (14% in 2010)
Pulmonary function: ALS (95% in 2008)
Reflex bronchoconstriction: Neurons (86% in 2012)
Respiratory alkalosis: renal compensation (49% in 2008)
Smoking cessation: Acute effects (62% in 2012)
VQ mismatch: Causes (9% in 2013)
V/Q mismatch - emphysema (44% in 2009)
Ventilatory response at altitude (44% in 2013)
Work of breathing: Neonate vs. adult (49% in 2010)

Renal/Urine/Electrolytes

Calcium chelation; transfusion (99% in 2009)
Hypovolemia- renin-angiotensin response (78% in 2013)
Mechanical ventilation: Renal effects (68% in 2012)
Postoperative ATN: Differential diagnosis (74% in 2010)
Postoperative oliguria: cause (76% in 2008)

Endocrine/Metabolic

Cyanide toxicity: Dx (78% in 2012)
Aerobic vs. anaerobic glycolysis (74% in 2013)
Hypoglycemia: Glucagon (67% in 2012)
Protein synthesis, stress induced (27% in 2012)

Hematologic

Anemia compensation (65% in 2008, 59% in 2011)
Blood oxygen transport (59.5% in 2008)
Febrile transfusion reaction mechanism (45% in 2011)
FFP Indications (67% in 2011)
Haldane effect (41% in 2009)
Isovolemic hemodilution compensation (28% in 2008)
Oxygen delivery index determinants (95% in 2009)
Oxygen saturation: PaO2 (71% in 2008)
P50 of hemoglobin: factors influencing (71% in 2008, 79% in 2011)
Refractory hemophilia (53% in 2008)

Neuromuscular Diseases and Disorders

Regional

Anesthetic absorption: regional anesthetic techniques (88% in 2008)
Ankle block: anatomy (37% in 2008)
Ankylosing spondylitis: Epidural risks (41% in 2011)
Axillary block limitations (74% in 2009)
Axillary block: complications (83% in 2009)
Axillary block: Median nerve rescue block (67% in 2010)
Axillary block: N block supplement (66% in 2011)
Epidural anesthetics: Respiratory effects (72% in 2009, 74% in 2012)
Femoral Nerve Block anatomy (31% in 2008, 49% in 2009, 55% in 2012)
Foot surgery: Regional anesthesia (51% in 2008, 77% in 2011)
Interscalene Block: Anatomy (57% in 2008)
Interscalene block side effects (67% in 2008)
Interscalene block: Technique (5% in 2013)
IV regional: Mechanism (78% in 2011)
Nerve block: stimulation current vs. distance (52% in 2008)
Neuraxial anesth: Cardiovascular effects (71% in 2012)
PDPH: Prevention (88% in 2012)
Post spinal back ache (73% in 2013)
Pseudocholinesterase synthesis (87% in 2008)
Regional anesthetic: foot surgery (51% in 2008, 77% in 2011)
Regional anesthetics: low molecular weight heparin (90% in 2008)
Retrobulbar vs. peribulbar block (66% in 2008, 59% in 2011)
Spread of epidural anesth (91% in 2013)
Stellate ganglion block: effects (60% in 2008, 70% in 2009)
Subdural injection: symptoms (62% in 2008)
Total knee replacement: Regional anesthesia techniques (82% in 2010)
Upper extremity nerve blocks: indications (98% in 2009)
Upper extremity regional management (32% in 2008)

Subspecialties

Critical Care

Acute septic shock (76% in 2009, 75% in 2012)
Arterial Blood Gas Interpretation and Acid/Base (also see section on Acid Base)

Cardiogenic shock: DDx (76% in 2013) Critical Care Pharmacology

Hyperchloremic metabolic acidosis (68% in 2012)
Hypophosphatemia: Muscle weakness (44% in 2013)
Infectious Disease

Nitric oxide: Toxicity (22% in 2012)
Nutrition

Postoperative SIRS/sepsis: Dx (77% in 2012)
Respiratory quotient: Energy sources (67% in 2013)
Shock: Pulmonary embolism (96% in 2013)
SID: Hyperchloremic acidosis (3% in 2013)
SpO2 effect of methemoglobin (88% in 2012)
Ventilator Management

Obstetric Anesthesia

(also see section on Obstetrics (Anesthesia Text))
2-Chloroprocaine onset (45% in 2010)
ABG: Pregnancy (60% in 2009)
Amniotic fluid embolus: Dx (92% in 2009, 95% in 2012)
Anesthesia techniques: 1st stage labor (83% in 2010)
Anesthesia: uterine muscle tone (90% in 2008)
Antiphospholipid synd: Mgmt in labor (63% in 2013)
Apgar scoring (48% in 2008, 49% in 2012)
Asthma: Postpartum hemorrhage treatment (71% in 2010)
Cervical cerclage: Anesthetic management (66% in 2010)
C-section: Morbidity (42% in 2012)
Difficult airway: C-section (53% in 2011)
Dx of Uterine rupture (37% in 2009, 48% in 2010)
EXIT procedure: Uterine atony (94% in 2010)
Fetal blood gas values (78% in 2009)
FHR: Causes of late decelerations (8% in 2013)
Fetal HR pattern: Maternal hypotension (76% in 2010)
Fetal HR pattern: Normal labor (68% in 2010)
Fetal perfusion during surgery (97% in 2012)
Gastric volume: breast milk vs. clear liquids (86% in 2008)
Herpes and pregnancy (62% in 2008)
Inhaled agents: Uterine tone (93% in 2011)
Magnesium: Hypotensive effect (41% in 2012)
Maternal mortality causes (93% in 2009)
Maternal physiology: Blood volume (84% in 2013)
Meconium aspiration: Rx (64% in 2012)
Methods: uterine relaxation (47% in 2009, 81% in 2012)
Neonatal apnea hypoxemia physiol (72% in 2011)
Neonatal resuscitation medication (73% in 2013)
Neuraxial anesthesia: cardiovascular effects (66% in 2009)
Neutral thermal environment: advantages (48% in 2008, 66% in 2011)
Nitroglycerin: Uterine relaxation (97% in 2010)
O2 delivery to fetus in labor (37% in 2009)
Oxytocic drugs: Indications (66% in 2013)
PCEA labor analgesia (87% in 2012)
Peripartum changes in CO (91% in 2011)
Placenta accreta: Risk factors (66% in 2010)
Placental ion exchange (64% in 2013)
Placental transfer: Anesth drugs (69% in 2011)
Placental transfer: anticholinergic (70% in 2009, 57% in 2012)
Placental transfer: local anesthetics (79% in 2009, 79% in 2012)
Postop uterine atony: Causes (72% in 2012)
Pre-term labor: treatment (51% in 2009)
Preeclampsia: Placental effects (60% in 2012)
Preeclampsia: Lab abnormalities (78% in 2010, 98% in 2011)
Pregnancy: Aspiration risk vs time (80% in 2011)
Pregnancy: Asthma + uterine atony (67% in 2011)
Pregnancy: asthma (78% in 2008)
Pregnancy: gastric function (57.5% in 2008)
Pregnancy: GE reflux mechanism (90% in 2010)
Pregnancy: Hematologic changes (85% in 2010)
Pregnancy: Heme and e-lyte changes (76% in 2011)
Pregnancy: hemodynamic effects (87% in 2008, 37% in 2011)
Pregnancy: inhalation induction (91% in 2008)
Pregnancy: laboratory measurements (71% in 2008)
Pregnancy: Lung volumes (88% in 2011)
Pregnancy: non-OB surg risks (73% in 2009, 77% in 2011, 68% in 2012)
Pregnancy: Plasma proteins (54% in 2011)
Pregnancy: SVT Rx (47% in 2009, 72% in 2012)
Primary pulmonary HTN and pregnancy (81% in 2013)
Surgery risk during pregnancy (84% in 2008)
Uptake & distribution: Pregnancy (95% in 2013)
Uterine atony (98% in 2008)
Uterine relaxation techniques (91% in 2008)
Uterine tone and anesthetics (96% in 2012)

Pain

Botox: pain relief mechanism (34% in 2009, 41% in 2012)
Cancer pain: WHO ladder (69% in 2013)
Celiac plexus block distribution (95% in 2011)
Celiac plexus block: complications (62% in 2008, 76% in 2009, 82% in 2012)
Celiac plexus block: indications (83% in 2008)
Celiac plexus block: Side effects (83% in 2010)
Chronic pain: cancer: methadone (68% in 2008)
Chronic pain: cancer: opioids (42% in 2008)
CRPS I

CRPS II: treatment (54% in 2008, 67% in 2011)
Discogenic pain: Symptoms (56% in 2013)
Fibromyalgia DDx (86% in 2011)
Herpes zoster: Rx (87% in 2012)
Low back pain: Etiologies (87% in 2013)
Lumbar sympathetic block: Indications (85% in 2012)
Lumbosacral radiculopathy: Mgmt (68% in 2012)
Myofascial pain syndrome: Dx (61% in 2012)
Myofascial pain: diagnosis (85% in 2008)
Neuromuscular diseases: muscle pain (56% in 2009)
Neuropathic pain: treatment (98% in 2008)
Phantom limb pain treatment (24% in 2011)
Postherpetic neuralgia: risk factors (53% in 2008, 72% in 2012)
Somatic pain vs. visceral pain (88% in 2008, 91% in 2011)
Stellate ganglion block: effects (60% in 2008, 70% in 2009, 65% in 2012)
Sympathetic block indications (20% in 2009)
TENS indications (55% in 2012)
Transdermal fentanyl indications (93% in 2009, 93% in 2012)
Trigeminal neuralgia: Rx (73% in 2009, 85% in 2012)
Trigger point injections indications (89% in 2009)
Ultrasound anatomy: Supraclav block (61% in 2013)
Upper extremity tourniquet pain prevention (73% in 2010)
WHO analgesic ladder (50% in 2010)

Pediatrics

Adult vs neonatal respiration (74% in 2013)
Beta-thalassemia: Newborn (97% in 2010)
Bupivacaine toxicity Rx (65% in 2012)
Caudal anesthesia (67% in 2009)
CDH: Ventilation strategy (82% in 2012)
Chronic pain: Methadone vs morphine (79% in 2011)
Congenital emphysema: Mgmt (85% in 2012)
Congenital heart disease: Prostaglandin treatment (23% in 2010)
Congenital heart disease: pulmonary hypertension treatment (74% in 2008)
Epiglottitis: Airway management (67% in 2012)
Ex-premature: Pulmonary Cx (72% in 2011)
Fetal Hb: Oxygen transport (86% in 2012)
Fluid replacement in peds (97% in 2009, 97% in 2012)
Fontan single ventricle phys (84% in 2013)
Gastroschisis: Abd closure pulm eff (88% in 2011)
Hypothermia: Infant vs. toddler (79% in 2010)
Hypovolemia signs: Pediatrics (8% in 2010)
Infant preop fasting: Breast milk (95% in 2011)
Intubation in Pierre Robin syndrome (76% in 2012)
Meconium: Tracheal suctioning (79% in 2010)
Meningomyelocele: Arnold-Chiari assoc (64% in 2011)
Myelomeningocele: Assoc anomalies (56% in 2013)
Neonatal bradycardia: treatment (68% in 2010)
Neonatal hypoxia: physiology (64% in 2008)
Neonatal nasal CPAP: mechanism (43% in 2011)
Neonatal resusc: Meconium (81% in 2011)
Neonatal resuscitation and meconium (71% in 2008)
Neonatal vs. adult cardiac physiology (67% in 2010)
Neonate: duration of post-anesthesia monitoring (35% in 2008)
Newborns: Dehydration assessment (18% in 2011)
Parental presence: Indications (83% in 2010)
Parental presence: Induction (61% in 2012)
Patent ductus arteriosis: Diagnosis (36% in 2010)
Pediatric circuit: Dead space (11% in 2012)
Pediatric dehydration: Clinical signs (72% in 2012)
Peds sleep apnea risk factors (50% in 2011)
PONV after pediatric surgery (97% in 2009, 96% in 2012)
Post-tonsillectomy complications (55% in 2012)
Postoperative apnea: post conceptual age (40% in 2008)
Preoperative anxiolysis in children (51% in 2009)
Prostaglandin for congenital heart: Dx (18% in 2009)
Pyloric stenosis: Electrolytes (85% in 2013)
Pyloric stenosis: Fluid therapy (43% in 2011)
Pyloric stenosis: metabolic abnormality (94% in 2010)
Sevo uptake: Infant vs. adult (86% in 2012)
Spinal anesthesia: Premie indications (86% in 2011)
Spinal block: Infant vs. adult (63% in 2012)
TE fistula: ETT positioning (87% in 2012)
Tet spell: Pharm Rx (30% in 2011)
Tetralogy of Fallot Rx (82% in 2009, 89% in 2012)
Tracheoesophageal fistula: Assoc anom (79% in 2013)
Work of breathing: Neonate vs. adult (49% in 2010)

Generic Clinical Sciences: Anesthesia Procedures, Methods, Techniques

Abdominal compartment syndrome: Diagnosis (74% in 2010)
ACC/AHA guidelines for periop CV eval (75% in 2013)
Acute hyperkalemia: treatment (66% in 2010)
Acute mountain sickness Rx (66% in 2011)
Addiction: Definition (77% in 2010)
Addiction: Risk factors (59% in 2012)
Aging (Physiologic Changes of Aging)

The Airway (also see section on Airway Management)

Aging: CNS changes (41% in 2013)
Amb Surg: Discharge delays (89% in 2012)
Ambulatory surgery costs (46% in 2012)
Anaphylaxis: Dx and Rx (98% in 2013)
Anes drugs and IOP (90% in 2011)
Anes management: penetrating eye injury (87% in 2009, 87% in 2012)
Anes techniques: suspected MH (99% in 2009)
Anesthesia for ECT: lidocaine effect (35% in 2009, 47% in 2012)
Anesthetic uptake: Right-to-left shunt (48% in 2011)
Anesthesiologist drug abuse: Fentanyl (91% in 2010)
Anesthesiologists: substance abuse (85% in 2009)
ASA guidelines: sedation (99% in 2008)
ASA Physical Status (55% in 2012)
ASA PS Class 2 vs 3 (86% in 2011)
ASA sedation guidelines (85% in 2009)
Aspiration mgmt: LMA (95% in 2012)
Automated anesthesia record: Advantages (87% in 2010)
Automated vs. Paper Anesthesia Records (90% in 2009, 95% in 2009)
Bowel distention (95% in 2009)
Burns: CO poisoning DDx (72% in 2011)
Carcinoid syndrome (70% in 2011)
Child-Pugh score: Factors (76% in 2012)
Closed claims: Brain damage (72% in 2010)
Clostridium tetani infection (15% in 2009)
Coag factors in hepatic disease (71% in 2012)
Compartment Syndrome: Dx (86% in 2009)
Complication bronchial blocker (95% in 2012)
Delayed emergence: differential diagnosis (74% in 2008)
Delayed emergence: DDx (83% in 2011)
DLT misplacement: Auscultation Dx (88% in 2011)
DNR and anesthesia (88% in 2011)
Donor hepatectomy: INR elevation (39% in 2012)
Double lumen tube placement (85% in 2008)
Down's syndrome: abnormalities (98% in 2008)
Down Syndrome anes implications (97% in 2011)
ECT: Contraindications (53% in 2012)
Endobronchial intubation (64% in 2008)
Epid steriod indications: radiculop (78% in 2011)
Epiglottitis

Esoph sphincter tone: Anes drugs (46% in 2011)
Ethical principles: Autonomy (97% in 2013)
Ethics: Speaker disclosure (91% in 2010)
Failed intubation: Rx (87% in 2012)
Fat embolism: Dx (84% in 2012)
Federal regulation agencies: Ors (72% in 2011)
Geriatrics: Autonomic function (72% in 2011)
Geriatrics: Muscle relaxants (42% in 2011)
Glycopyrrolate: Adverse effects (92% in 2012)
Head down position: hypoxemia (41% in 2009)
Helium advantages: Small-bore tube (63% in 2010)
Hepatic synthetic capacity: Dx (70% in 2012)
Hip Fx: Fat embolism mgmt (80% in 2011)
Hyperbaric chamber: MAC effect (73% in 2010)
Hyperbaric Oxygen: indications (78% in 2009)
Hypothermia: Cold OR mechanism (56% in 2011)
Hypoxemia: closing capacity vs. FRC (90% in 2008)
Hypoxia during pneumonectomy: treatment (90% in 2010)
Hypoxemia: ventilator management (56% in 2009)
ICU: Enteral nutrition (56% in 2011)
IHSS (85% in 2008, 46% in 2009)
Implantable cardiac defibrillator: interventions (36% in 2009)
Induced hypothermia (84% in 2013)
Inhalational anesthesia: ventilatory effects (55% in 2009)
Interscalene block side effects (75% in 2011)
Intestinal obstruction: N2O (47% in 2011)
Intravascular: Extracellular volume ratio (47% in 2009, 58% in 2012)
Intubation in Pierre-Robin (76% in 2009)
Joint commission: anesthesia standards (31% in 2008)
Laryngoscopic view: Grading (64% in 2012)
Laparoscopy: Air vs. N2O (93% in 2013)
Laparoscopy complications (74% in 2012)
Laparoscopy: Elevated ETCO2 DDx (94% in 2011)
Laparoscopy: ETCO2 (95% in 2008)
Laparoscopy: increased PaCO2 (91% in 2009, 84% in 2012)
Laryngospasm causes (97% in 2008)
Laser resistant ET (68% in 2013)
Laryngospasm mechanism (40% in 2010)
Laryngospasm treatment options (65% in 2010)
Laser-safe endotracheal tubes (68% in 2010)
Liposuction: lidocaine toxic dose (0% in 2008)
Lithotomy position: Nerve Injury (68% in 2010)
Liver transplant: Fxn of allograft (73% in 2012)
Lower extremity nerves: Sensory distribution (57% in 2008)
Lumbar nerve roots: Innervation (58% in 2010)
Lung isolation (81% in 2013)
Lung protection ventilation: Pressure goal (58% in 2010)
LV function in geriatric pts (89% in 2013)
Malignant hyperthermia: Associated disorders (25% in 2010)
Management: acute heart failure (66% in 2009)
Management: lumbosacral radiculopathy (71% in 2009)
Mech valve: Antibiotic prophylaxis (27% in 2012)
Mediastinal tumor: Airway obstruction (92% in 2010)
Mediastinoscopy: vascular compression (85% in 2009)
Mediastinoscopy (79% in 2008)
MOCA requirements (95% in 2009)
Moderate sedation: ASA guidelines (39% in 2011)
Monitored anesthesia care: Requirements (89% in 2012)
Monitoring for residual NMB (86% in 2009)
Monitoring: barbiturate coma (22% in 2008)
Morbid Obesity: post-op complications (70% in 2009, 73% in 2012)
MRI: Monitoring hazards (75% in 2012)
Myotonic dystrophy: Preop eval (29% in 2011)
N2O & intraocular gas (72% in 2011)
Nasal fiberoptic intubation (83% in 2009)
National Practitioner Database (15% in 2013)
Nd: YAG laser characteristics (41% in 2011)
Needle stick injury mgmt (93% in 2011)
NPO recommendation infants (91% in 2013)
Obesity: airway eval (64% in 2009, 73% in 2012)
OLT: Hypocalcemia mech (73% in 2013)
Ondansetron: Side effect (6% in 2013)
Opioids and aging (41% in 2012)
OR costs: Labor vs materials (30% in 2011)
Organ donor: Rx of DI (87% in 2012)
Osteomyelitis: diagnosis (87% in 2008)
Outpatient surgery contraindications (83% in 2013)
PACU bypass: Rationale (67% in 2010)
PACU bypass: Stage I bypass criteria (23% in 2010)
Pharmacology in the elderly (58% in 2013)
Physician impairment: Referral (63% in 2010)
Pain management: Rib fracture (76% in 2009, 89% in 2012)
POCD: Predictors (94% in 2013)
Postop blindness: Dx (91% in 2012)
Postop nausea: Rx (74% in 2012)
Post-Operative Nausea and Vomiting (PONV)

Predictor difficult intubation (7% in 2013)
Preop ECG: Indications (98% in 2013)
Preoptic anterior hypothalamus: Dx (91% in 2012)
Propofol: Administration guidelines (67% in 2012)
Radiation exposure vs distance (39% in 2011)
Radiculopathy: steroid epidural (65% in 2008)
Root cause analysis: Essential elements (83% in 2010)
Ruptured diaphragm: Dx (87% in 2013)
Sentinel event: Definition (85% in 2012)
Septic shock therapy (97% in 2008)
Septic shock: stress response mediators (55% in 2008)
Septic shock: Vasopressin treatment (78% in 2010)
Septic shock: Hypotension Rx (90% in 2011)
Shock states: DDx (83% in 2011)
Sitting position: BP measurement (93% in 2010)
Spinal Anesthesia (also see section on Spinal Anesthesia)

Spinal cord stim indications (65% in 2011)
Spinal cord stimulator: Reprogramming (77% in 2010)
Spinal stenosis: Diagnosis (90% in 2010)
Spine osteomyelitis Dx (91% in 2011)
Tourniquet deflation (82% in 2012)
Tumescent anesthesia Cx (32% in 2011)
Tumescent liposuction: lidocaine dose (28% in 2009)
Tumescent liposuction complications (33% in 2010)
Upper airway anatomy (64% in 2013)
Vasodilators: Renal blood flow (78% in 2009, 86% in 2012)
Vecuronium: PD in geriatric patients (85% in 2013)

Statistics

(also see section on Biostatistics)
AIMS: EMR (83% in 2013)
Categorical data: Chi square test (52% in 2010)
Chi-squared test application (55% in 2011)
Chi-squared test: appropriate data (46% in 2008)
Clinical trial: study power (93% in 2008)
Definition: Sensitivity and specificity (52% in 2012)
Definition: Standard deviation (79% in 2012)
Local anes concentration calc (86% in 2013)
O2 transport: Quantitative aspects (53% in 2011)
Odds ratio calculation (61% in 2008)
Paired vs. unpaired t-test (64% in 2009)
Power analysis for sample size (90% in 2012)
Power analysis: Study design (90% in 2010)
Preoperative testing: Bayes theorem (64% in 2010)
SE vs. SD calculation (9% in 2010)
Statistical analysis: power (99% in 2009)
Statistics: ANOVA indications (79% in 2010)
Statistics: median (89% in 2009)
Statistics: Test of proportions (63% in 2013)
Study design: blinding (78% in 2008, 69% in 2011)
T-test: Paired vs. unpaired (16% in 2011)
Time units definition (76% in 2011)
Type I statistical error: definition (80% in 2008)
Use of Chi-square (59% in 2012)
VE/PaCO2 relationship: Hypoxia (53% in 2010)

Studying for exams? Answer the Review Question of the Day, many of which are based upon ABA Keywords.


(previous 200) (next 200)

Pages in category "ABA Keywords"

There are 200 pages in this category.

2

A

A cont.

B

C

C cont.
(previous 200) (next 200)
Retrieved from "http://www.openanesthesia.org/index.php?title=Category:ABA_Keywords"
Personal tools
Follow us
Add to Google
Recommend us
Editorial Board
sponsor